bearish
China Healthcare Weekly(Oct.29)-Logic of CAR-T,New Stage For Vaccine Industry,Autoimmune Drug Market
Xinyao has highlighted this Insight as a Top Pick
56 Views31 Oct 2021 09:19
The insight analyzed the different logics of drug development and commercialization for CAR-T, a new stage of development for domestic vaccine industry and opportunity in China autoimmune drug market.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- China Healthcare Weekly (Nov.19) - Q4 Healthcare Rebound, New Policy on API, Beijing Stock Exchange22 Nov 2021
- China Healthcare Weekly (Nov.12)-Medical Insurance Negotiation,Spring Coil VBP,Valuation Upside Down15 Nov 2021
- China Healthcare Weekly (Nov.5) - Final Two Domestic Policy Risks, Outlook of China CXO Industry07 Nov 2021
- China Healthcare Weekly(Oct.29)-Logic of CAR-T,New Stage For Vaccine Industry,Autoimmune Drug Market31 Oct 2021
- JW Therapeutics (2126.HK) - Concerns on Commercialization23 Sep 2021
- CanSino Biologics (688185.CH/6185.HK) 2021/1H - Concerns on Key Products and the Outlook07 Sep 2021
- Chongqing Zhifei Biological Products (300122.CH) - Could Zhifei Support Its Valuation?26 Apr 2021
x